Evidence map›Paper›PMID 37474506›Full record

ArticleNature communications2023

Computational analysis of peripheral blood smears detects disease-associated cytomorphologies.

José Guilherme de Almeida, Emma Gudgin, Martin Besser, William G Dunn, Jonathan Cooper, Torsten Haferlach, George S Vassiliou, Moritz Gerstung

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

José Guilherme de AlmeidaEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.ORCID 0000-0002-1887-0157
Emma GudginDepartment of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
Martin BesserDepartment of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
William G DunnDepartment of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7246-5198
Jonathan CooperWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Torsten HaferlachMunich Leukemia Laboratory GmbH, Munich, Germany.ORCID 0000-0003-0196-2837
George S VassiliouWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. gsv20@cam.ac.uk.ORCID 0000-0003-4337-8022
Moritz GerstungEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK. moritz.gerstung@dkfz.de.ORCID 0000-0001-6709-963X
University of Cambridge · GBChampalimaud Foundation · PTEuropean Bioinformatics Institute · GBMunich Leukemia Laboratory (Germany) · DEWellcome/MRC Cambridge Stem Cell Institute · GBWellcome Sanger Institute · GB

Funding

Cancer Research UK 23015Cancer Research UK C22324/A23015Department of HealthMedical Research Council MC_PC_17230Wellcome Trust
6 · The paper itself

Abstract

Many hematological diseases are characterized by altered abundance and morphology of blood cells and their progenitors. Myelodysplastic syndromes (MDS), for example, are a group of blood cancers characterised by cytopenias, dysplasia of hematopoietic cells and blast expansion. Examination of peripheral blood slides (PBS) in MDS often reveals changes such as abnormal granulocyte lobulation or granularity and altered red blood cell (RBC) morphology; however, some of these features are shared with conditions such as haematinic deficiency anemias. Definitive diagnosis of MDS requires expert cytomorphology analysis of bone marrow smears and complementary information such as blood counts, karyotype and molecular genetics testing. Here, we present Haemorasis, a computational method that detects and characterizes white blood cells (WBC) and RBC in PBS. Applied to over 300 individuals with different conditions (SF3B1-mutant and SF3B1-wildtype MDS, megaloblastic anemia, and iron deficiency anemia), Haemorasis detected over half a million WBC and millions of RBC and characterized their morphology. These large sets of cell morphologies can be used in diagnosis and disease subtyping, while identifying novel associations between computational morphotypes and disease. We find that hypolobulated neutrophils and large RBC are characteristic of SF3B1-mutant MDS. Additionally, while prevalent in both iron deficiency and megaloblastic anemia, hyperlobulated neutrophils are larger in the latter. By integrating cytomorphological features using machine learning, Haemorasis was able to distinguish SF3B1-mutant MDS from other MDS using cytomorphology and blood counts alone, with high predictive performance. We validate our findings externally, showing that they generalize to other centers and scanners. Collectively, our work reveals the potential for the large-scale incorporation of automated cytomorphology into routine diagnostic workflows.

Indexed as

AnemiaAnemia, MegaloblasticMyelodysplastic SyndromesBlood CellsHumansNeutrophils

Identifiers

PMID37474506
PMCPMC10359268
OpenAlexW4384924855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.